“ovarian-cancer” Archives

Entry Author Date Location
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
Atara Bio Pays the Price for Delayed IPO, Sinks in Debut 10/16/14 San Francisco
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
Texas Biotech Leaders Doubt CPRIT Will Get Its Groove Back 01/24/14 Texas
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Ex-Prometheus Exec Takes the Reins at Dallas’ Gradalis 07/23/13 Texas
When You Are Facing a Tsunami of Barriers, Surf Like a Woman 07/02/13 San Francisco
Gradalis’s Fang Bares Its Teeth in Fighting Ovarian Cancer 05/15/13 Texas
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial 01/27/09 Boston
Page 1 of 1